Golfyeti wrote "With an unproven science, especially with so many high-profile failures with epigenetic therapies, that we here understand were non-selective BETi's, and to which the market assigned multi-billion dollar values during phase III, the market has become extrememly gun shy until final results are in and proven successful."

What high-profile epigenetic therapy failures are you referring to? Did you mean high-profile cardiovascular outcome trial failures?